logo
What to Know About Treating Insomnia

What to Know About Treating Insomnia

Health Line19-05-2025

You can treat insomnia with lifestyle changes, such as exercise, behavioral therapies, and medications. Your doctor can help you decide which option is best for you.
Plenty of treatment options for insomnia are available. Good sleep habits and a balanced diet can remedy many cases of insomnia. Behavior therapy or medication may be necessary in some cases.
It's important to determine whether or not an underlying issue or medical condition is causing your insomnia.
Some cases of insomnia are a result of stress or some other emotional or physical condition that needs separate treatment. Many times, sleep patterns return to usual when these conditions are successfully treated.
Read on for more information about what you can do to treat insomnia.
Lifestyle changes
Often, making lifestyle changes can relieve your insomnia. You might want to try:
going to bed when you feel tired
using your bedroom only for activities that don't stimulate the brain
trying to go to bed and wake up at the same time every day
reducing the stressors in your life that are disrupting your sleep
You may also want to incorporate other lifestyle changes, such as:
Avoiding smoking
If you currently smoke, try a smoking cessation program. Nicotine is a stimulant that triggers insomnia and influences your sleep patterns.
Ask your doctor about smoking cessation programs or products to help you quit if you're having difficulty quitting.
Watching what you drink
Avoid drinking excessive amounts of alcohol. Alcohol is a sedative that may induce sleep initially, but it can disrupt deeper stages of sleep that allow your body to rest fully.
Caffeinated drinks, such as coffee and soft drinks, are other stimulants to avoid. A 2023 review found that caffeine consumption can:
decrease total sleep time
increase the time it takes to fall asleep
reduce sleep efficiency
It's advised to avoid drinking alcohol at least three hours before bed and avoid consuming caffeine at least eight hours before bed. This may vary from person to person.
Drinking too much of any fluid before bedtime can disrupt sleep with repeated nighttime trips to the bathroom.
Exercising
Regular physical activity for at least 30 minutes can encourage a good night's sleep. Keep exercising even if you don't see immediate results.
A 2023 review found that exercise can help you fall asleep better and improve the quality of your sleep. This is because exercise stimulates the release of melatonin, which is a hormone that helps with sleep and wake cycles.
Regular exercise can also help manage stress and improve mood.
Maintaining a balanced diet
Avoid foods that are difficult to digest, particularly if you eat them late at night or right before bed, as this can make it difficult to sleep.
Instead, consume foods high in protein and essential amino acids. Some fruits, such as kiwis and cherries, also contain sleep-inducing antioxidants.
Complementary approaches
Complementary approaches include psychological and behavioral therapies that can teach you how to make your environment more conducive to sleep.
Behavioral therapies are often conducted by a psychologist, psychiatrist, or another trained healthcare professional.
Behavioral therapies may be as effective as sleep medications, such that therapies are often the first line of treatment for people with insomnia.
Complementary approaches may include:
Relaxation techniques
Progressive muscle relaxation, biofeedback, and breathing exercises are ways to reduce anxiety at bedtime. These strategies help you control your:
breathing
heart rate
muscle tension
mood
A warm bath before bedtime, a massage, and light stretching all work to relax the body and could help you wind down at night.
Cognitive behavioral therapy
In group sessions or one-on-one counseling, mental health therapists can help you learn to change negative patterns of thinking.
This can help you learn to replace worried or fearful thoughts with more pleasant, relaxing thoughts. This type of mindset is more helpful for developing healthy sleep habits.
Sleep restriction
Sleep restriction requires that the time you spend in bed is temporarily restricted, causing partial sleep deprivation. You're then more tired the next night.
Once your sleep has improved, your time in bed gradually increases.
Light therapy
Some sleep experts recommend light exposure for people who tend to fall asleep too early at night or wake up too early in the morning. This helps adjust your internal clock.
During times of the year when it's light outside later in the evenings, going outside for 30 minutes or using a medical-grade light box can help adjust your sleep patterns.
Insomnia medications
Your doctor may turn to medication if lifestyle changes and behavior therapies don't help your insomnia.
Let your doctor know if you're experiencing symptoms of depression. This may be the root of your insomnia and will require other types of treatment.
Talk with your doctor about a medication treatment plan if you have insomnia.
Prescription sleep aids
Prescription medications for insomnia include:
Doctors don't recommend taking sleeping pills for more than 2 to 3 weeks, as they can become habit-forming. Dose and duration will vary depending on your diagnosis, medical history, and current condition.
Some common prescription sleep medications, also called Z-drugs, include:
eszopiclone (Lunesta)
ramelteon (Rozerem)
trazodone (Desyrel)
zaleplon (Sonata)
zolpidem (Ambien)
doxepin (Silenor)
estazolam (Prosom)
triazolam (Halcion)
suvorexant (Belsomra)
These prescription sleep medications slow activity in the brain, which can improve the quality of your sleep.
Other aspects of sleep that sleep medications can affect include:
total sleep time
waking up after falling asleep
how quickly you fall asleep
Sleep medications sometimes have unpleasant or even dangerous side effects. Make sure to discuss the side effects of any medications they might prescribe with your doctor.
Also, talk with your doctor immediately about any side effects you experience while taking the medication.
Over-the-counter sleep aids
Many people prefer to use nonprescription sleep aid medications, such as antihistamines, to initiate drowsiness. But these shouldn't be used as a long-term insomnia treatment.
Antihistamines can also reduce the quality of sleep and cause side effects, such as:
daytime drowsiness
dry mouth
blurred vision
People also commonly use melatonin as a sleep aid to fall asleep faster. Melatonin is a dietary supplement — not a medication — available at most pharmacies.
While safe for short-term use, melatonin shouldn't be used in the long term as its safety hasn't been evaluated for long-term use. It's also possible to overdose on melatonin if taken incorrectly.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Suspected case of Measles under investigation in Lee County, Alabama
Suspected case of Measles under investigation in Lee County, Alabama

Yahoo

timean hour ago

  • Yahoo

Suspected case of Measles under investigation in Lee County, Alabama

LEE COUNTY, Ala. (WRBL) — The Alabama Department of Public Health (ADPH) is investigating a suspected case of measles in Lee County involving an unvaccinated individual who was not yet eligible to receive the vaccine. The case is currently under review as part of ADPH's standard communicable disease response. Health officials say while the individual is confirmed to be unvaccinated, they were too young to have received the measles, mumps, and rubella (MMR) vaccine. The ADPH is now working closely with local medical providers to identify any other unvaccinated individuals who may need the MMR vaccine as a precaution. 'At this time, given that most eligible Alabamians are vaccinated against measles, the risk for an outbreak remains low,' ADPH officials said in a statement. 'However, some individuals will need to be vaccinated as part of this ongoing investigation.' Measles is a highly contagious virus that spreads through coughing, sneezing, and close contact. In rare but serious cases, it can lead to pneumonia, brain swelling, and even death — particularly in young children, the immunocompromised, and unvaccinated populations. 'Measles vaccine is safe and highly effective in producing lifelong immunity against this potentially deadly disease,' said Dr. Karen Landers, ADPH's Chief Medical Officer and a pediatrician. 'Our citizens can protect themselves and others by ensuring that all eligible persons are vaccinated.' ADPH says anyone who may have been exposed is being contacted directly by health officials or their healthcare providers. Due to patient privacy laws and HIPAA regulations, no additional personal information about the suspected case is being released at this time. For more information on measles symptoms, vaccine eligibility, and how to protect yourself, visit: Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Shelter calls on KC community amidst nationwide mental illness surge
Shelter calls on KC community amidst nationwide mental illness surge

Yahoo

timean hour ago

  • Yahoo

Shelter calls on KC community amidst nationwide mental illness surge

KANSAS CITY, Mo. — Mental health issues are on the rise across the United States, according to one Kansas City shelter. They say it's causing more people to experience homelessness, especially in Kansas City. A new report from Citygate Network shows that 31% of Shelter KC guests were unhoused for the first time. That same report showed that 62% of those people reported that they've struggled with mental illness, which is well above the 47% national average. 'I've seen the demographics get younger,' said James Kohoutek, the Associate Director at Shelter KC. 'I've seen the amount of first-time homelessness increase as well as chronic homelessness. So, it's a rough situation we have.' Kansas City police stop potential sideshow during First Friday; enforcement continues Kohoutek shared research that shows limited access to health care, family trauma and financial strain are all contributing factors to mental illness. According to him, many just need a safe space and the right resources to make progress. 'Someone who sits off to the side away from the group, and then they start to sit more towards the group, and then they start to participate in the group discussion and the group classes,' he said, speaking on the progress he's seen in some cases. 'They start to engage in mental health services, they engage with their recovery coach or counselor. And you just see them come alive in a beautiful way.' Now, the shelter is calling on the KC community to get involved to break the cycle. Whether it's through volunteering or simply learning more about the crisis, Shelter KC believes it'll take everyone to make lasting change. 'We all need people in our lives to help us move forward, whether you're on the streets or standing behind a news camera. We all need that healthy support,' Kohoutek echoed. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)

Yahoo

timean hour ago

  • Yahoo

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)

HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will be presented at the 85th Scientific Sessions of American Diabetes Association (ADA) in Chicago, U.S. Details of the Poster Presentations Poster Number: 750-P Abstract Title: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study Session Type: General Poster Session Location: Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, 2025 12:30 PM - 1:30 PM (Chicago Time), i.e., Monday Jun 23, 2025 1:30 AM - 2:30 AM (Beijing Time) Poster Number: 847-P Abstract Title: ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model Session Type: General Poster Session Location: Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, 2025 12:30 PM - 1:30 PM (Chicago Time), i.e., Monday Jun 23, 2025 1:30 AM - 2:30 AM (Beijing Time) About ASC30 ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection administrations. ASC30 is a new chemical entity (NCE), with U.S. and global compound patent protection until 2044. About ASC47 ASC47 is an adipose-targeted, ultra-long-acting subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small molecule agonist, discovered and developed in-house at Ascletis. ASC47 possesses unique and differentiated properties to enable adipose targeting, resulting in dose-dependent high drug concentrations in the adipose tissue. Topline data from its Phase Ib single subcutaneous injection studies in Australia in participants with elevated low-density lipoprotein cholesterol (LDL-C) (NCT06427590) have been released. The Phase I clinical trial of ASC47 in combination with semaglutide for the treatment of obesity (NCT06972992) is ongoing in the U.S., and the first participants were dosed in May 2025. About the American Diabetes Association (ADA) Established in 1940, the American Diabetes Association (ADA) is dedicated to preventing and curing diabetes and to improving the lives of all people affected by diabetes. It has grown into one of the foremost nonprofit organizations in diabetes advocacy around the world. Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The 85th Scientific Sessions of ADA will be held in Chicago, U.S. from June 20 to 23, 2025. About Ascletis Pharma Inc. Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange ( covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on metabolic diseases by addressing unmet medical needs from a global perspective. Ascletis has multiple clinical stage drug candidates in its metabolic disease pipeline. For more information, please visit Contact: Peter Vozzo ICR Healthcare 443-231-0505 (U.S.) Ascletis Pharma Inc. PR and IR teams +86-181-0650-9129 (China) pr@ ir@ View original content: SOURCE Ascletis Pharma Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store